These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 17624477

  • 21. Local botulinum toxin type A injections in the treatment of spastic toes.
    Suputtitada A.
    Am J Phys Med Rehabil; 2002 Oct; 81(10):770-5. PubMed ID: 12362118
    [Abstract] [Full Text] [Related]

  • 22. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK.
    Holmes RJ, Connell LA.
    Disabil Rehabil; 2019 Mar; 41(6):720-726. PubMed ID: 29126361
    [Abstract] [Full Text] [Related]

  • 23. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
    Picelli A, Lobba D, Midiri A, Prandi P, Melotti C, Baldessarelli S, Smania N.
    Clin Rehabil; 2014 Mar; 28(3):232-42. PubMed ID: 23945164
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G.
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [Abstract] [Full Text] [Related]

  • 25. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.
    Ploumis A, Varvarousis D, Konitsiotis S, Beris A.
    Disabil Rehabil; 2014 Dec 15; 36(4):313-8. PubMed ID: 23672209
    [Abstract] [Full Text] [Related]

  • 27. Treatment of pain and limited movement of the shoulder in hemiplegic patients with botulinum toxin a in the subscapular muscle.
    Yelnik AP, Colle FM, Bonan IV.
    Eur Neurol; 2003 Dec 15; 50(2):91-3. PubMed ID: 12944713
    [Abstract] [Full Text] [Related]

  • 28. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A, Micello MF, Panza F, Fortunato F, Picelli A, Smania N, Logroscino G, Fiore P, Ranieri M.
    Clin Rehabil; 2015 Jan 15; 29(1):50-8. PubMed ID: 24917588
    [Abstract] [Full Text] [Related]

  • 29. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, Hughes A.
    J Rehabil Med; 2010 Jan 15; 42(1):81-9. PubMed ID: 20111849
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov 15; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 31. Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: a randomized double-blind controlled trial.
    Im S, Park JH, Son SK, Shin JE, Cho SH, Park GY.
    Clin Rehabil; 2014 Jun 15; 28(6):604-13. PubMed ID: 24452704
    [Abstract] [Full Text] [Related]

  • 32. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
    Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, Al Khawaja I, Brozman M, Kanovský P, Skorometz A, Slawek J, Reichel G, Stenner A, Timerbaeva S, Stelmasiak Z, Zifko UA, Bhakta B, Coxon E.
    Cerebrovasc Dis; 2003 Jun 15; 15(4):289-300. PubMed ID: 12686794
    [Abstract] [Full Text] [Related]

  • 33. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.
    Magid M, Reichenberg JS, Poth PE, Robertson HT, LaViolette AK, Kruger TH, Wollmer MA.
    J Clin Psychiatry; 2014 Aug 15; 75(8):837-44. PubMed ID: 24910934
    [Abstract] [Full Text] [Related]

  • 34. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
    Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG.
    Obstet Gynecol; 2006 Oct 15; 108(4):915-23. PubMed ID: 17012454
    [Abstract] [Full Text] [Related]

  • 35. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group.
    Pain Med; 2011 Nov 15; 12(11):1607-14. PubMed ID: 21692970
    [Abstract] [Full Text] [Related]

  • 36. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
    Díaz-Llopis IV, Gómez-Gallego D, Mondéjar-Gómez FJ, López-García A, Climent-Barberá JM, Rodríguez-Ruiz CM.
    Clin Rehabil; 2013 Aug 15; 27(8):681-5. PubMed ID: 23411793
    [Abstract] [Full Text] [Related]

  • 37. A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.
    Ferrari A, Maoret AR, Muzzini S, Alboresi S, Lombardi F, Sgandurra G, Paolicelli PB, Sicola E, Cioni G.
    Res Dev Disabil; 2014 Oct 15; 35(10):2505-13. PubMed ID: 24995688
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of botulinum toxin type A treatment of functional impairment of degenerative hip joint: Preliminary results.
    Marchini C, Acler M, Bolognari MA, Causero A, Volpe D, Regis D, Rizzo A, Rosa R, Eleopra R, Manganotti P.
    J Rehabil Med; 2010 Jul 15; 42(7):691-3. PubMed ID: 20603701
    [Abstract] [Full Text] [Related]

  • 39. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr 15; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.